ALTHOUGH GONORRHEA had been recognized clinically since antiquity, the etiological agent was not identified until 1879. By 1906, the gonococcus had been successfully cultured and differentially stained. With the advent of sulfonamides and penicillin, easy treatment became available for the cure of diagnosed cases. It soon became apparent, however, that the control of this disease would not be possible with therapeutic programs alone. During 1961, 265,665 cases of gonorrhea were reported in the US.1 It was felt, however, that the reported number was about one tenth the actual incidence or more than 2,000,000 cases a year. Throughout the world, cases of gonorrhea have shown a steady increase, especially in teen-age groups.
In almost every report, males outnumber females 3:1 in seeking medical attention for gonorrhea. With syphilis, however, statistics indicate that the prevalence is approximately the same in both sexes. Since both diseases are acquired in like manner, this